HOLOGIC INC Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Hologic Inc quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2018 to 2023.
  • Hologic Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending December 30, 2023 was -$824M, a 909% decline year-over-year.
  • Hologic Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $416M, a 64.4% decline from 2022.
  • Hologic Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $1.17B, a 149% increase from 2021.
  • Hologic Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was $469M, a 373% increase from 2020.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $416M -$753M -64.4% Sep 25, 2022 Sep 30, 2023 10-K 2023-11-21
2022 $1.17B +$700M +149% Sep 26, 2021 Sep 24, 2022 10-K 2023-11-21
2021 $469M +$370M +373% Sep 27, 2020 Sep 25, 2021 10-K 2023-11-21
2020 $99.2M +$164M Sep 29, 2019 Sep 26, 2020 10-K 2022-11-15
2019 -$64.9M -$191M -151% Sep 30, 2018 Sep 28, 2019 10-K 2021-11-16
2018 $126M Oct 1, 2017 Sep 29, 2018 10-K 2020-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.